Pharmacogenomics and genetic risk factors of coronary artery disease
Coronary artery disease (CAD) is the most prevalent disorder and the leading cause of death worldwide. There are a number of CAD medications, which are effective and safe in most patients, but have been associated with adverse reactions such as angioedema induced by angiotensin I-converting enzyme i...
Main Author: | Duan, Qingling. |
---|---|
Format: | Others |
Language: | en |
Published: |
McGill University
2008
|
Subjects: | |
Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=115665 |
Similar Items
-
Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats
by: Yannick Marc, et al.
Published: (2021-08-01) -
Skin Reactions with Losartan and Enalapril in Cardiac Patients
by: Fariba Iraji, et al.
Published: (2012-03-01) -
Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
by: Karolina Torres Santos, et al. -
Administration of Tranexamic Acid as Treatment for Angiotensin Converting Enzyme Inhibitor-Induced Angioedema: A Case Report
by: Sohun Awsare, et al.
Published: (2021-07-01) -
Visceral Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: Case Report
by: Beatriz Frutuoso, et al.
Published: (2016-05-01)